Recursion is a clinical-stage biotechnology company using AI to industrialise drug discovery. It combines large biological image datasets with ML to identify disease-biology relationships and predict therapeutic candidates. Recursion's platform has generated one of the largest proprietary biological datasets in existence, enabling AI-driven target identification and compound screening at new scale.
- AI-powered target identification
- Large-scale biological image analysis
- ML compound screening
- Disease-biology mapping
- Partnership programs
Pros
- Pioneer in AI-driven drug discovery at scale
- Proprietary dataset is a competitive moat
- Active clinical programmes validate the approach
Cons
- Pharmaceutical industry-specific
- Platform not publicly available
No reviews yet. Be the first to leave a review!
Log in to leave a review.
| Pricing | paid |
| Category | Data & Analytics |
| Views | 4 |
| Clicks | 2 |
| Added | Jun 02, 2026 |
| Source | Manual Entry |